Investment Trusts

RTW Biotech Opportunities Ltd

RTW:LSE

RTW Biotech Opportunities Ltd

  • Price (USD)1.48
  • Today's Change0.00 / 0.00%
  • Shares traded134.76k
  • 1 Year change28.98%
  • Beta0.6459
Data delayed at least 20 minutes, as of Nov 21 2024 16:35 GMT.
More ▼
Total returns on $1000
1Y
Fund/benchmarkChange
PriceRTW Biotech Opportunities Ltd (Ordinary Share)+27.59%
NAVRTW Biotech Opportunities Ltd (Ordinary Share)+31.97%
Morningstar's BenchmarkRussell 2000 Biotech Growth [50.00%]; Nasdaq Biotechnology Index [50.00%]--

Key statistics

On Thursday, RTW Biotech Opportunities Ltd (RTW:LSE) closed at 1.48, -14.45% below its 52-week high of 1.73, set on Jul 31, 2024.
52-week range
Today
1.14Nov 23 20231.73Jul 31 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding335.71m
Market cap496.86m USD
Total assets651.28m USD
Total expense ratio1.97%
High1.48
Low1.46
Previous close1.48
Average volume805.28k
YTD Change+5.53%
Beta0.6459
Diluted NAV (est)1.94
Diluted NAV (last pub)1.94
Premium/Discount-23.71%
Net Gearing0.00%
Data delayed at least 20 minutes, as of Nov 21 2024 16:35 GMT.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.